Protected: Nothing Is Inert

There is no excerpt because this is a protected post.
The Global Treatment Room

Korea is building, sculpting, and repairing faces with donor dermis, fish DNA, and a new bile acid. Issue 8 reads the evidence, follows the money, and asks what it all means for your treatment room.
Delayed Onset

The industry built an empire on temporary hyaluronic acid, but the immune system plays a permanent game. We unpack the reversal myth, fibrotic tissue, and the clinical reality of delayed-onset filler complications.
Information Asymmetry

Every dollar in aesthetic medicine passes through four sets of hands. Issue 6 maps the asymmetry from patient to private equity.
The Industry’s <1% problem

We swept complications under the rug for so long the rug started to buckle. This issue throw out the rug and starts building the floor.
The Myths We Inject With

The safety culture in medical aesthetics was built on five assumptions the published literature has already dismantled. The liability window is open.
The Architecture of Aging

Multi-modality doubled five year patient retention. The plan is the treat, and most practices never draw the blueprint.
VO Preparedness Is Improvised

Sixty-one injectors, zero consensus, and a $600,000 median settlement. Hope is not a protocol.
The Manifesto

Vanity is good. Vanity is right. Vanity works. The case for medical aesthetics as the upward surge of humanity, plus Obagi crashes the filler wars.